Last reviewed · How we verify
Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD (ILDnose)
The ILDnose study a multinational, multicenter, prospective, longitudinal study in outpatients with pulmonary fibrosis. The aim is to assess the accuracy of eNose technology as diagnostic tool for diagnosis and differentiation between the most prevalent fibrotic interstitial lung diseases. The value of eNose as biomarker for disease progression and response to treatment is also assessed. Besides, validity of several questionnaires for pulmonary fibrosis is investigated.
Details
| Lead sponsor | Erasmus Medical Center |
|---|---|
| Status | ACTIVE_NOT_RECRUITING |
| Enrolment | 600 |
| Start date | Sun Nov 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Dec 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Pulmonary Fibrosis
Interventions
- Electronic nose
Countries
France, Netherlands, United Kingdom, Germany, Australia